Japan: sales value of medicine by product type

In fiscal year 2022, medical prescription drugs were the largest product type regarding the sales value of medicine of Japanese pharmaceutical manufacturers and sellers, accounting for a sales value of approximately 14.3 trillion Japanese yen. That year, the total sales value of medicine of pharmaceutical manufacturers and sellers amounted to around 16.5 trillion yen, including overseas sales.

Sales value of medicine of pharmaceutical manufacturers and sellers in Japan in fiscal year 2022, by product type (in billion Japanese yen)

Characteristic	Sales value in billion Japanese yen
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

March 2024

More information

Region

Japan

Survey time period

fiscal year 2022; the Japanese fiscal year starts on April 1 of the stated year and ends on March 31 of the following year

Special properties

excluding 23 companies that have not entered pharmaceutical sales by product type; including overseas sales

Supplementary notes

Figures were based on a survey. The survey was conducted among 306 certified companies that manufacture and sell pharmaceutical products and belong to one of 15 organizations of The Federation of Pharmaceutical Manufacturers’ Associations of Japan.

100 Japanese yen equal 0.66 U.S. dollars or 0.61 euros as of April 2024.
Values have been rounded.

Citation formats